HIV-1 reduces Aβ-degrading enzymatic activities in primary human mononuclear phagocytes

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 6925-6932

  Lan, Xiqian ^a   Xu, Jiqing ^a   Kiyota, Tomomi ^a   Peng, Hui ^a   Zheng, Jialin C ^a   Ikezu, Tsuneya ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; THIORPHAN; VIRUS PROTEIN;

ARTICLE; BRAIN INFECTION; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; LYSOSOME; MICROGLIA; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL;

AMYLOID BETA-PEPTIDES; CELLS, CULTURED; COGNITION DISORDERS; ENDOPEPTIDASES; HIV INFECTIONS; HIV-1; HUMANS; INSULYSIN; NEPRILYSIN; PHAGOCYTES;

EID: 79959568671     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100211     Document Type: Article

References (56)

1. Gisslén, M., J. Krut, U. Andreasson, K. Blennow, P. Cinque, B. J. Brew, S. Spudich, L. Hagberg, L. Rosengren, R. W. Price, and H. Zetterberg. 2009. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 9: 63.
2. Valcour, V. G., C. M. Shikuma, M. R. Watters, and N. C. Sacktor. 2004. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1): S79-S86.
3. Pulliam, L. 2009. HIV regulation of amyloid beta production. J. Neuroimmune Pharmacol. 4: 213-217.
4. Esiri, M. M., S. C. Biddolph, and C. S. Morris. 1998. Prevalence of Alzheimer plaques in AIDS. J. Neurol. Neurosurg. Psychiatry 65: 29-33.
5. Xu, J., and T. Ikezu. 2009. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol. 4: 200-212.
6. Green, D. A., E. Masliah, H. V. Vinters, P. Beizai, D. J. Moore, and C. L. Achim. 2005. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19: 407-411.
7. Guallar, J. P., J. M. Gallego-Escuredo, J. C. Domingo, M. Alegre, J. Fontdevila, E. Martínez, E. L. Hammond, P. Domingo, M. Giralt, and F. Villarroya. 2008. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS 22: 575-584.
8. Bell, R. D., and B. V. Zlokovic. 2009. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118: 103-113.
9. Hardy, J. A., and G. A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
10. Hardy, J., and D. J. Selkoe. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
11. Deane, R., A. Sagare, and B. V. Zlokovic. 2008. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Curr. Pharm. Des. 14: 1601-1605.
12. Zlokovic, B. V. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
13. Cosenza, M. A., M. L. Zhao, and S. C. Lee. 2004. HIV-1 expression protects macrophages and microglia from apoptotic death. Neuropathol. Appl. Neurobiol. 30: 478-490.
14. Merrill, J. E., and I. S. Chen. 1991. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5: 2391-2397.
15. Lee, C. Y., and G. E. Landreth. 2010. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117: 949-960.
16. Gate, D., K. Rezai-Zadeh, D. Jodry, A. Rentsendorj, and T. Town. 2010. Macrophages in Alzheimer's disease: the blood-borne identity. J. Neural Transm. 117: 961-970.
17. Malm, T. M., M. Koistinaho, M. Pärepalo, T. Vatanen, A. Ooka, S. Karlsson, and J. Koistinaho. 2005. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 18: 134-142.
18. Simard, A. R., D. Soulet, G. Gowing, J. P. Julien, and S. Rivest. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502. (Pubitemid 43221886)
19. Zhao, L., S. Lin, K. R. Bales, V. Gelfanova, D. Koger, C. Delong, J. Hale, F. Liu, J. M. Hunter, and S. M. Paul. 2009. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J. Neurosci. 29: 3603-3612.
20. Blasko, I., R. Veerhuis, M. Stampfer-Kountchev, M. Saurwein-Teissl, P. Eikelenboom, and B. Grubeck-Loebenstein. 2000. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol. Dis. 7(6 Pt B): 682-689.
21. Rossner, S., J. Apelt, R. Schliebs, J. R. Perez-Polo, and V. Bigl. 2001. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurosci. Res. 64: 437-446.
22. Hartlage-Rübsamen, M., U. Zeitschel, J. Apelt, U. Gärtner, H. Franke, T. Stahl, A. Günther, R. Schliebs, M. Penkowa, V. Bigl, and S. Rossner. 2003. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 41: 169-179. (Pubitemid 36262194)
23. Yamamoto, M., T. Kiyota, M. Horiba, J. L. Buescher, S. M. Walsh, H. E. Gendelman, and T. Ikezu. 2007. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 170: 680-692.
24. Iwata, N., S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H. J. Lee, E. Hama, Y. Sekine-Aizawa, and T. C. Saido. 2000. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6: 143-150.
25. Iwata, N., S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N. P. Gerard, C. Gerard, E. Hama, H. J. Lee, and T. C. Saido. 2001. Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550-1552.
26. Kurochkin, I. V., and S. Goto. 1994. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345: 33-37.
27. Carson, J. A., and A. J. Turner. 2002. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 81: 1-8.
28. Eckman, E. A., and C. B. Eckman. 2005. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem. Soc. Trans. 33: 1101-1105.
29. Vardy, E. R., A. J. Catto, and N. M. Hooper. 2005. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. Trends Mol. Med. 11: 464-472.
30. Wang, D. S., D. W. Dickson, and J. S. Malter. 2006. beta-Amyloid degradation and Alzheimer's disease. J. Biomed. Biotechnol. 2006: 58406.
31. Hama, E., K. Shirotani, H. Masumoto, Y. Sekine-Aizawa, H. Aizawa, and T. C. Saido. 2001. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J. Biochem. 130: 721-726.
32. Tanzi, R. E., R. D. Moir, and S. L. Wagner. 2004. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43: 605-608.
33. Hickman, S. E., E. K. Allison, and J. El Khoury. 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28: 8354-8360.
34. El-Amouri, S. S., H. Zhu, J. Yu, R. Marr, I. M. Verma, and M. S. Kindy. 2008. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am. J. Pathol. 172: 1342-1354.
35. Farris, W., S. G. Schütz, J. R. Cirrito, G. M. Shankar, X. Sun, A. George, M. A. Leissring, D. M. Walsh, W. Q. Qiu, D. M. Holtzman, and D. J. Selkoe. 2007. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am. J. Pathol. 171: 241-251.
36. Dorfman, V. B., L. Pasquini, M. Riudavets, J. J. López-Costa, A. Villegas, J. C. Troncoso, F. Lopera, E. M. Castaño, and L. Morelli. 2010. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease. Neurobiol. Aging 31: 1743-1757.
37. Rempel, H. C., and L. Pulliam. 2005. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19: 127-135. (Pubitemid 40409531)
38. Daily, A., A. Nath, and L. B. Hersh. 2006. Tat peptides inhibit neprilysin. J. Neurovirol. 12: 153-160.
39. Yamamoto, M., T. Kiyota, S. M. Walsh, J. Liu, J. Kipnis, and T. Ikezu. 2008. Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J. Immunol. 181: 3877-3886.
40. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, D. S. Burke, et al. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167: 1428-1441.
41. Borgmann, K., H. E. Gendelman, and A. Ghorpade. 2005. Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue. Methods Mol. Biol. 304: 49-70.
42. Chao, C. C., G. Gekker, S. Hu, and P. K. Peterson. 1994. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J. Immunol. 152: 1246-1252.
43. Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65: 3973-3985.
44. Xu, J., K. Tsutsumi, K. Tokuraku, K. A. Estes, S. I. Hisanaga, and T. Ikezu. 2011. Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity. J. Neurochem. 116: 192-204.
45. Kiyota, T., M. Yamamoto, H. Xiong, M. P. Lambert, W. L. Klein, H. E. Gendelman, R. M. Ransohoff, and T. Ikezu. 2009. CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS ONE 4: e6197.
46. Barros, N. M., M. Campos, P. A. Bersanetti, V. Oliveira, M. A. Juliano, G. Boileau, L. Juliano, and A. K. Carmona. 2007. Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides. Biol. Chem. 388: 447-455.
47. Hama, E., K. Shirotani, N. Iwata, and T. C. Saido. 2004. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J. Biol. Chem. 279: 30259-30264.
48. Leoni, L. M., and G. A. Losa. 1996. Changes in membrane enzymes and glycosphingolipids in lymphocytes from HIV-1 - infected and noninfected intravenous drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11: 188-197.
49. Miyauchi, K., Y. Kim, O. Latinovic, V. Morozov, and G. B. Melikyan. 2009. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
50. Wang, R., J. S. Malter, and D. S. Wang. 2010. N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells. J. Alzheimers Dis. 19: 179-189.
51. Wang, D. S., N. Iwata, E. Hama, T. C. Saido, and D. W. Dickson. 2003. Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 310: 236-241.
52. Shinall, H., E. S. Song, and L. B. Hersh. 2005. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 44: 15345-15350.
53. Jiang, Q., C. Y. Lee, S. Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T. M. Willson, J. L. Collins, et al. 2008. ApoE promotes the proteolytic degradation of Abeta. Neuron 58: 681-693. (Pubitemid 351778466)
54. Liu, Y., M. Jones, C. M. Hingtgen, G. Bu, N. Laribee, R. E. Tanzi, R. D. Moir, A. Nath, and J. J. He. 2000. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6: 1380-1387.
55. Arora, S., M. Husain, D. Kumar, H. Patni, S. Pathak, D. Mehrotra, V. K. Reddy, L. R. Reddy, D. Salhan, A. Yadav, et al. 2009. Human immunodeficiency virus downregulates podocyte apoE expression. Am. J. Physiol. Renal Physiol. 297: F653-F661.
56. András, I. E., S. Y. Eum, W. Huang, Y. Zhong, B. Hennig, and M. Toborek. 2010. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin. Mol. Cell. Neurosci. 43: 232-243.